Découvrez les Meilleures Cliniques et Coûts des traitements de cancer de l'estomac en Italie 2024

Le professeur Riccardo Rosati est chef du service de chirurgie gastro-intestinale (GI) de l'hôpital de recherche San Raffaele. Dirige l'un des « centres à haut volume » les plus reconnus pour la chirurgie de l'œsophage en Italie. Son service possède une vaste expérience en chirurgie ouverte et mini-invasive du tube digestif, notamment dans le domaine des maladies de l’intestin antérieur et du gros intestin. Le service hospitalier dirigé par le professeur Rosati traite environ 2 000 cas chirurgicaux par an. L'expérience professionnelle Depuis 2014 — Chef du Département de Chirurgie GI de l'Ospedale San Raffaele de Milan 2009-2014 — Fondateur et directeur du Centre universitaire de recherche et de soins sur les maladies œsophagogastriques (CURE) de la Faculté de médecine internationale de l'Université de Milan 1996-2014 — Chef du service de chirurgie générale et mini-invasive de l'hôpital de recherche Humanitas 1985-1996 — Chirurgien au Département de Chirurgie Générale et Oncologique de la Faculté de Médecine de l'Université de Milan. Éducation 1980 — Faculté de Médecine de l'Université de Milan — Diplôme en médecine générale 1985 — Faculté de Médecine de l'Université de Milan — Spécialité chirurgie générale 1988 — Faculté de Médecine de l'Université de Turin — Spécialité en chirurgie thoracique 1990 — Certification du Conseil national pour présider le département de chirurgie générale. Activité scientifique A écrit plus de 300 publications. Adhésion Le Collège américain des chirurgiens L'Association italienne des chirurgiens hospitaliers L'Association Européenne de Chirurgie Endoscopique La Société internationale pour les maladies de l'œsophage La Société européenne pour les maladies de l'œsophage La Société Italienne de Chirurgie Oncologique La Société Italienne de Chirurgie Endoscopique et des Nouvelles Technologies La Société de Chirurgie du Tract Gastro-intestinal L'Association chirurgicale européenne Le Groupe italien de recherche sur le cancer gastrique.

Dr Braun's primary responsibilities include direct leadership and execution of complex surgeries, including gastric bypass, sleeve gastrectomy, and other advanced metabolic and bariatric procedures. He has developed solid experience in managing the different clinical challenges present in obese patients, providing them with personalized and optimized care to ensure positive long-term outcomes.His surgical practice is based on an in-depth methodology and a careful look at the latest technological innovations in the field of bariatric surgery. He has actively worked to implement advanced protocols and continually improve operational techniques, while maintaining the highest standards of patient safety and care.With over 2000 operations performed as a surgeon specializing in oncology, he has developed extensive experience and expertise in laparoscopic and robotic surgery applied to the care of cancer patients.As a primary operator, he has successfully conducted a wide range of laparoscopic and robotic surgeries for the treatment of oncological conditions, including gastrointestinal, urological, gynecological and other solid tumors. His surgical practice has focused on the application of advanced techniques, using cutting-edge laparoscopic instruments and robotic systems

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).